key: cord-0912765-jaw6a51e
authors: Ing, Richard J.; Barrett, Cindy; Chatterjee, Debnath; Twite, Mark; Whitney, Gina M.
title: Perioperative preparations for COVID -19 -The Pediatric Cardiac Team Perspective
date: 2020-04-28
journal: J Cardiothorac Vasc Anesth
DOI: 10.1053/j.jvca.2020.04.032
sha: eac6b4a3a80d7d31e99ff826581692bcd552d84f
doc_id: 912765
cord_uid: jaw6a51e

nan

2 avoid non-essential travel. 1 As of April 6 th 2020, there are over 1.3 million reported positive patients in the world, and over 81,000 people have died of the disease. In just under a month, COVID-19 has become the third leading cause of death in the United States of America, following heart disease and cancer. 2 It is reported that asymptomatic individuals can transmit 4 Therefore, estimating the asymptomatic proportion of the population is a useful method to gauge the true burden of the disease and better model true estimates of COVID-19 transmission potential. 5 Using recent evacuation and quarantine data, the asymptomatic proportion of COVID-19 positive individuals is reported as 17 -30% 5, 6 As perioperative physicians with expertise in providing anesthesia for critically ill patients undergoing open heart surgery and other cardiac procedures, the clinical skills of the cardiac anesthesiologist may be helpful in the care of the anticipated large number of critically ill COVID-19 adult patients. 7 Our critical care colleagues may need our assistance as illustrated in three reports from Hubei province, where 20-25% of critically ill COVID-19 patients required intubation and ventilation and invasive monitoring in the intensive care unit (ICU) where 60-70% of ICU patients developed adult respiratory disease syndrome (ARDS). [8] [9] [10] [11] [12] The purpose of this freestanding editorial is to review the literature and present current recommendations to inform the pediatric cardiac team preparing to take care of all children and adults during this COVID-19 pandemic. 3 An institution's response to the COVID-19 pandemic may be influenced by the proximity to an epicenter of COVID-19 outbreak and the institution's prior experience with a pandemic. Most healthcare institutions have rapidly set up local and regional COVID-19 command centers with key stakeholders from local government, hospital leadership, emergency medicine, anesthesiology, intensive care, infectious disease, surgery, and nursing. 13, 14 These teams meet once or twice per day in online virtual meetings to address the rapidly changing needs and logistical planning needed for a tiered response of the hospital system to the anticipated surge in patients that will present with COVID-19. In addition, it is very helpful to set up a local scientific advisory committee (SAC) of key experts from all disciplines. 15 Meetings are held virtually to rapidly assess peer-reviewed evidence and personal correspondence with colleagues treating COVID-19 patients in other parts of the world. The SAC can quickly assemble documents to help inform the COVID-19 command centers, who can then disseminate critical information to all members of the health care team.

There is no emergency in a pandemic. Taking the time to 'don and doff' personal protective equipment (PPE) correctly protects our colleagues and us so that we can all continue to safely care for sick patients in the long term. 16 It has been argued that previous pandemic plans and their existing ethical guidance are often ill-equipped to anticipate and facilitate the navigation of unique ethical challenges that arise during infectious disease pandemics. 17 This uncertainty, for example, in the scale of anticipated patients and potential ventilator shortages during a pandemic, is difficult to anticipate. 17 To meet the challenges of the COVID-19 pandemic, professional societies, health care institutions, and hospital networks have set up local and 4 regional ethics committees and developed guidelines to help inform decision making for critically ill patients, including front-line clinicians, hospital administrators, professional societies, and public health or government officials. 15 It is critical to limit the risk of exposure within the team as well as plan for potential staffing shortages, as team members exposed to COVID-19 will need 14 days of quarantine before coming back to work. Health care facilities cannot inform healthcare workers (HCW) if any colleagues they work with have tested positive for COVID-19. Furthermore, not all HCWs who are ill with COVID-19 symptoms are tested.

HCWs with presumed COVID-19 illness should not return to work until at least 7 days have passed since symptoms first appeared and at least 3 days of recovery as defined by resolution of fever without the use of fever-reducing medications and improvement in respiratory symptoms (e.g. cough, shortness of breath). Other efforts to limit HCW exposure include screening all team members on entry to their healthcare facility, wearing masks in clinical areas, and social distancing. 16 Usually, occupational health teams assess the potential exposures by staff who test COVID positive. It is safest to assume that anyone we are interacting with is positive, and all HCWs should use established best practices. 16 The rules of engagement must be followed; wash hands or sanitize them regularly, maintain social distance, wear appropriate masks in clinical areas, follow all protocols and policies, and HCWs should not come to work if they are sick. 18 For health care systems, the CDC and WHO guidelines for PPE should be followed. Local variations may be made depending on what equipment is available. Strategies to decrease the risk of exposure to viral particles during aerosolizing procedures include the use of a Powered Air Purifying Respirator (PAPR) devices or a N95 mask with a face shield. 19 Due to the limited 5 availability of PPE, many organizations have created a central airway team to limit PPE usage to a small number of highly trained individuals. During the SARS outbreak in 2003, HCWs who performed intubations had an increased risk of contracting the disease (odds ratio (OR) 6.6), as were those who performed noninvasive ventilation (OR 3.1), tracheostomy (OR 4.2), and manual ventilation before intubation (OR 2.8). 20, 21 Organizing and Allocating PPE Organization of PPE, airway equipment, and anesthetic supplies in special COVID carts that may be wheeled to the bedside or used in the operating room avoids the contamination of larger anesthesia workstations. Simpler strategies also include the use of large clear "To-go" bags containing PPE such as protective face masks, filters to fit on the bag-mask, face shields, gowns, and gloves. Clear plastic household storage boxes can house PAPR machines and hoods, that can be easily cleaned between patient use.

Due to the need to closely monitor available supplies and their use, there may be an advantage to creating a team of 'PPE Guardians.' These guardians are often nursing staff from low census units that can be retrained as PPE guardians to help their front-line colleagues. Each PPE guardian must be familiar with the workflow of their assigned unit. They are trained to provide 'just in time training' for appropriate PPE use for colleagues and then monitor the donning and doffing process to ensure that team members do not contaminate themselves or others. 22 Areas in the hospital that are not being utilized during this pandemic, such as conference rooms, can be used for PPE storage. The presence of a PPE guardian allows teams to 6 understand what PPE is available as well as provide oversight of PPE distribution. Guardians can also aid in helping teams clean and reuse some PPE. Many centers, including our own, are using ultraviolet light sterilization of N95 masks. This sterilization method uses ultraviolet C radiation to inactivate microorganisms by causing deoxyribonucleic acid (DNA) damage, thereby preventing replication. 23

Within health care facilities, specific rooms are pressurized relative to their surrounding areas in order to protect their contents or the patients from surrounding airborne contaminants.

Operating rooms, pharmacy workrooms, trauma/resuscitation areas are among those where positive pressure state is designed to protect sterile medical equipment and patients from airborne bacteria, fungi, and viruses. These positively pressured areas are among the cleanest in the health care facility. Under normal operating circumstances, these steps help to ensure a sterile operating environment with the goal of minimizing the likelihood of surgical site infection. However, with the current COVID-19 pandemic, it is recommended that operating rooms be converted to negative pressure rooms (similar to triage and waiting rooms, microbiology laboratories, soiled workrooms, janitor's closets), so that infectious transmission or chemical contamination originating from within the room does not occur. 24 Conceptually, the design of ventilation systems within the hospital requires air movement from Conversion of a positive pressure room to a negative pressure room may be accomplished by building an anteroom at the site of patient entry into the operating room and sealing off additional access points to the room. Airflow within the operating room must also be reversed. 24, 27 The anteroom allows the passage of equipment and personnel without contaminating the surrounding environment. It should be large enough for the passage of a large hospital bed and permit adequate space for donning and doffing of PPE. Also, it should have a self-closing door so that negative pressure in the room remains. The considerations for these changes are complex and require close collaboration with hospital epidemiology, facilities management and industrial hygiene specialists. 27 In the context of a pandemic, minimizing environmental contamination by respiratory droplets becomes essential to maintaining the safety of HCWs, while maintaining efficient patient flow throughout the hospital. The essential role of environmental services staff members is often underrecognized and underappreciated. Following the use of an operating room for a COVID- 8 19 patient, allowing adequate time for aerosolized particles to settle and for air exchanges to occur (usually 60-90 minutes) is essential for the safety of environmental services staff members. This is counter to the usual production pressure which governs the perioperative environment. 28, 29 A thorough cleaning of all surfaces within the operating room during a terminal cleaning while wearing full PPE is essential to prevent virus transmission to others who will be in contact with these same surfaces within the hours or days that follow. Checklists designed to improve the thoroughness of the cleaning process help to ensure that operating room surfaces do not serve as a source of infection for HCWs. Additionally, testing for residual biologic residue following cleaning, such as adenosine triphosphate testing, may serve as a check on the thoroughness of operating room cleanliness. 30

Despite the almost universal moratorium on elective surgery during this pandemic, many newborns with complex congenital heart disease will require heart catheterization 31, 32 One important consideration that can affect urgent and emergent cardiac surgical decision making, is the current shortage of blood products being reported during the 9 COVID-19 pandemic. 33 Although it is not very likely that the coronavirus can be transmitted through allogeneic blood transfusion, this remains to be fully determined. 33 Therefore, it is important for all cardiac surgery programs to procure enough blood products for high-risk cardiac surgeries that usually require additional blood products. 33 Many hospitals and organizations have created exposure risk stratifications based on clinical duties and procedures. High-risk procedures are defined as those that cause aerosolization of viral particles and often involve instrumentation of a patient's airway during intubation and bronchoscopy. 18 The cardiac anesthesiologist regularly takes care of patients for these procedures. The cardiac catheterization laboratory should be prepared to manage unrelated cardiac conditions or patients with cardiac manifestations of COVID-19. While most patients with COVID-19 rapidly improve after a mild disease course, a significant proportion develop hypoxemic respiratory failure with viral pneumonia and diffuse alveolar disease that can progress to the need for veno-venous or arteriovenous extracorporeal membrane oxygenation (ECMO). Therefore, it is highly likely there will be an increased need for the pediatric catheterization laboratory to transition adolescents and young adults to ECMO in the hope of a recovery from COVID-19. 34 The Extracorporeal Life Support Organization (ELSO) and all of the ELSO worldwide chapters have released guidelines to describe when and how to use ECMO in COVID-19 patients. 34 They do not recommend institutions starting a new ECMO program just for COVID-19 patients, there are also currently shortages of ECMO equipment worldwide. 35 Even prior to ECMO, COVID-19 positive patients may undergo a number of investigative and therapeutic procedures requiring the expertise of the cardiac anesthesiologist. 10 The perioperative anesthetic management of COVID-19 positive patients has been published in a very timely manner and several excellent review articles are available. 12, 21, 36, 37 The risk of aerosolization and airborne transmission of SARS-CoV-2 during airway generating medical procedures (AGMPs) is especially pertinent to the pediatric cardiac anesthesiologists given the high viral loads within the nose and nasopharynx of COVID-19 positive patients. 38 Aerosol formation during AGMP may be divided into procedures that induce the patient to produce aerosols (bronchoscopy, intubation, cough-like force during cardiopulmonary resuscitation, etc.) and procedures that mechanically generate aerosols themselves (bag-mask ventilation, nasotracheal suctioning, tracheostomy tube change, noninvasive ventilation, highfrequency oscillatory ventilation, etc.). 39 Among the various AGMPs, a systematic review showed that tracheal intubation was associated with the highest risk of transmission of acute respiratory infections to HCWs. 40 Experimental studies on the stability of SARS-CoV-2 in aerosols and on various surfaces (plastic, stainless steel, copper, and cardboard) showed that SARS-CoV-2 remains viable up to 72 hours, indicating that aerosol and fomite transmission is plausible. 40 The use of a three-layered clear plastic drape configuration during extubation in a simulated mannequin model has been shown to significantly limit aerosolization and droplet spray. 41 The first layer was placed under the head of the mannequin, a second torso-drape layer was applied from the neck down covering the chest, and finally, an over-head top drape that was draped over the mannequin's head to prevent contamination of the surrounding surfaces, including the HCW. Similarly, experiments in cadaveric models showed a high risk of aerosolization during endoscopic endonasal surgery. 42 The pediatric cardiac anesthesiologist will be called upon to help with placement of the transesophageal echocardiography (TEE) 11 probe in COVID-19 patients, because it is considered a significant AGMP. 43 Recent guidelines by the American, British and Italian Societies of Echocardiography recommend that only a limited goal-directed examination should be performed in emergency life-saving situations, ideally with the TEE probe in a protective sleeve. An experienced airway proceduralist such as cardiac anesthesiologists may be the best HCW to pass the echo probe, in full recommended PPE. The TEE results should be reviewed well away from the patient. [43] [44] [45] [46] [47] The Italian Society of Interventional Cardiology (GISE), and the American College of Cardiology's (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI) recently published consensus statements on the care of COVID-19 patients in the cardiac catheterization laboratory. 28, 29 During procedures in the catheterization laboratory, the risk of radiation necessitates wearing a protective lead apron and thyroid shield before donning PPE.

Another important consideration is to remove all possible emergency medications that may be required during the procedure from the anesthesia workstation. This will prevent the reopening of the anesthesia workstation and potential contamination of all anesthetic supplies in the workstation. Ideally, the anesthetic workstation should be covered in a plastic sheet as a barrier to reentry to help minimize cross-contamination. Catheterization laboratories and cardiac operating rooms use positive ventilation systems and are not designed for infection isolation. Therefore, these rooms will require conversion to an air neutral or negative pressure room in order to safely care for COVID-19 patients. Additionally, the room will require a terminal clean at the end of the procedure.

The role of the cardiac anesthesiologist in the intensive care unit 12 In preparation for the COVID-19 pandemic, it is most important for hospitals to be able to increase their ICU beds in order to able to care for the surge in COVID-19 patients. An example of this is a team in Italy who had to quickly ensure that enough ICU beds were available and that all staff were fully trained in the safe use of PPE. 14 . 48 Health care organizations have a limited number of respiratory therapists or intensivists. Adding to the challenge of a surge in the patient population, staff members may become ill, leaving ICU teams understaffed. 49 Cardiac anesthesiologists are very likely to be called upon to aid in ICU patient care due to their expertise in cardio-pulmonary physiology and procedural skills. Familiarity with pulmonary, vascular, and cardiac physiology enables the cardiac anesthesiologist with a unique skill set to care for COVID-19 patients in an expanded ICU setting. Some emergency room and ICU teams have developed procedural teams. Similar to airway teams, the most experienced personnel on these teams are able to obtain vascular access on unstable patients. 14 Depending on the unit workload, these team members may also be part of the airway team. This allows a small group of experts to be exposed to a patient during times of high potential risk of viral aerosolization.

Team members who are in a high risk category for SARS-CoV-2 infection due to age or comorbidities, should not be expected to participate in these COVID-19 teams, but encouraged to support the team in other ways by taking care of patients at low risk of viral infection..

The pediatric cardiac anesthesiologist is in a unique position to play a significant leadership role in the current rapidly changing COVID-19 pandemic. This freestanding editorial has highlighted the important hospital and regional initiatives where their assistance can help guide medical 13 decision making. Additionally, considerations for the anesthetic care in the catheterization laboratory and cardiac operating room of COVID-19 patients has been reviewed.

Center for Disease Control and Prevention. Coronavirus Pandemic 2020

Top 15 Causes of Death in the

Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster

Potential Presymptomatic Transmission of SARS-CoV-2

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship

Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)

Management of Critically Ill Adults With COVID-19

Characteristics of COVID-19 infection in Beijing

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020. (epub ahead of print

Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

COVID-19 Infection: Implications for Perioperative and Critical Care Physicians

Maximizing the Calm Before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19)

Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy

Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement

To Protect Healthcare Workers Better, To Save More Lives

Ethics for pandemics beyond influenza: Ebola, drug-resistant tuberculosis, and anticipating future ethical challenges in pandemic preparedness and response

IPCPPE_use-332020.331492-eng

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review

Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience. Anesthesiology. 2020. (epub ahead of print)

Personal protective equipment during the COVID-19 pandemic -a narrative review

Ultraviolet germicidal irradiation: possible method for respirator disinfection to facilitate reuse during COVID-19 pandemic

Implementing a negative-pressure isolation ward for a surge in airborne infectious patients

Effect of ventilation rate on air cleanliness and energy consumption in operation rooms at rest

Conversion of operating theatre from positive to negative pressure environment

Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC's Interventional Council and SCAI

Italian Society of Interventional Cardiology (GISE) Position Paper for Cath lab-specific Preparedness Recommendations for Healthcare providers in case of suspected

Cleaning operating rooms Available at

Anesthetic Management of Patients with COVID 19

Infections during Emergency Procedures

Anesthetic Management of Patients Undergoing Aortic Dissection Repair With Suspected Severe Acute Respiratory Syndrome Coronavirus-2

The Essential Role of Patient Blood Management in a Pandemic: A Call for Action

Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure

Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology

Perioperative Management of Patients Infected with the Novel Coronavirus: Recommendation from the Joint Task Force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists. Anesthesiology. 2020.(epub ahead of print) doi: Anesthesiology

Practical considerations in the anaesthetic management of patients during a COVID-19 epidemic. Anaesthesia. 2020.(epub ahead of print) doi: Anaesthesia

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Nosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures. Viruses. 11, 2019. (epub ahead of print) Viruses

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.(epub ahead of print)

Clear plastic drapes may be effective at limiting aerosolization and droplet spray during extubation: implications for COVID-19..(epub ahead of print

Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies. Int Forum Allergy Rhinol. 2020.(epub ahead of print) Int Forum Allergy Rhinol

Journal of Cardiothoracic and Vascular Anesthesia. 2020.(epub ahead of print)

Expert opinion of the Working Group on Echocardiography of the Polish Cardiac Society on performing echocardiographic examinations during COVID-19 pandemic

Statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak

Clinical guidance regarding provision of echocardiography during the COVID-19 pandemic

Italian Society of Echocardiography and Cardiovascular Imaging

COVID-19 Checklist for hospital preparing for the reception and care of coronavirus 2019 (COVID-19) patients